| American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults MA Sekeres, G Guyatt, G Abel, S Alibhai, JK Altman, R Buckstein, H Choe, ... Blood advances 4 (15), 3528-3549, 2020 | 158 | 2020 |
| Practical assessment and management of vulnerabilities in older patients receiving systemic cancer therapy: ASCO guideline update W Dale, HD Klepin, GR Williams, SMH Alibhai, C Bergerot, ... Journal of Clinical Oncology 41 (26), 4293-4312, 2023 | 105 | 2023 |
| NCCN guidelines® insights: older adult oncology, version 1.2021: featured updates to the NCCN guidelines E Dotan, LC Walter, IS Browner, K Clifton, HJ Cohen, M Extermann, ... Journal of the National Comprehensive Cancer Network 19 (9), 1006-1019, 2021 | 105 | 2021 |
| A phase I trial of single-agent reolysin in patients with relapsed multiple myeloma DW Sborov, GJ Nuovo, A Stiff, T Mace, GB Lesinski, DM Benson Jr, ... Clinical cancer research 20 (23), 5946-5955, 2014 | 89 | 2014 |
| Multiple myeloma in the older adult: better prospects, more challenges TM Wildes, A Rosko, SA Tuchman Journal of clinical oncology 32 (24), 2531-2540, 2014 | 89 | 2014 |
| Proteomic characterization of circulating extracellular vesicles identifies novel serum myeloma associated markers SW Harshman, A Canella, PD Ciarlariello, K Agarwal, OE Branson, ... Journal of proteomics 136, 89-98, 2016 | 81 | 2016 |
| Incidence and survival of hematological cancers among adults ages≥ 75 years JL Krok‐Schoen, JL Fisher, JA Stephens, A Mims, S Ayyappan, ... Cancer medicine 7 (7), 3425-3433, 2018 | 71 | 2018 |
| Use of a comprehensive frailty assessment to predict morbidity in patients with multiple myeloma undergoing transplant AE Rosko, Y Huang, DM Benson, YA Efebera, C Hofmeister, S Jaglowski, ... Journal of geriatric oncology 10 (3), 479-485, 2019 | 70 | 2019 |
| REGN5458, a BCMA x CD3 bispecific monoclonal antibody, induces deep and durable responses in patients with relapsed/refractory multiple myeloma (RRMM) D Madduri, A Rosko, J Brayer, J Zonder, WI Bensinger, J Li, L Xu, ... Blood 136, 41-42, 2020 | 66 | 2020 |
| Ninety-minute daratumumab infusion is safe in multiple myeloma H Barr, J Dempsey, A Waller, Y Huang, N Williams, N Sharma, ... Leukemia 32 (11), 2495-2518, 2018 | 64 | 2018 |
| Reduced intensity conditioned allograft yields favorable survival for older adults with B‐cell acute lymphoblastic leukemia AE Rosko, HL Wang, M de Lima, B Sandmaier, HJ Khoury, A Artz, ... American journal of hematology 92 (1), 42-49, 2017 | 53 | 2017 |
| Implementing a multidisciplinary approach for older adults with cancer: geriatric oncology in practice CJ Presley, JL Krok-Schoen, SA Wall, AM Noonan, DC Jones, E Folefac, ... Bmc Geriatrics 20, 1-9, 2020 | 50 | 2020 |
| Approach to the older adult with multiple myeloma R Mina, S Bringhen, TM Wildes, S Zweegman, AE Rosko American Society of Clinical Oncology Educational Book 39, 500-518, 2019 | 50 | 2019 |
| T cell transcriptional profiling and immunophenotyping uncover LAG3 as a potential significant target of immune modulation in multiple myeloma F Lucas, M Pennell, Y Huang, DM Benson, YA Efebera, M Chaudhry, ... Biology of Blood and Marrow Transplantation 26 (1), 7-15, 2020 | 47 | 2020 |
| Survivorship care for older adults with cancer: U13 conference report EJ Guerard, G Nightingale, K Bellizzi, P Burhenn, A Rosko, AS Artz, ... Journal of geriatric oncology 7 (4), 305-312, 2016 | 43 | 2016 |
| Association of prediagnostic frailty, change in frailty status, and mortality after cancer diagnosis in the women’s health initiative EMC Feliciano, C Hohensee, AE Rosko, GL Anderson, ED Paskett, ... JAMA network open 3 (9), e2016747-e2016747, 2020 | 41 | 2020 |
| Associations of high‐dose melphalan pharmacokinetics and outcomes in the setting of a randomized cryotherapy trial YK Cho, DW Sborov, M Lamprecht, J Li, J Wang, EM Hade, Y Gao, ... Clinical Pharmacology & Therapeutics 102 (3), 511-519, 2017 | 36 | 2017 |
| Autologous hematopoietic stem cell transplant induces the molecular aging of T-cells in multiple myeloma A Rosko, C Hofmeister, D Benson, Y Efebera, Y Huang, J Gillahan, ... Bone marrow transplantation 50 (10), 1379-1381, 2015 | 34 | 2015 |
| Clinical presentation, risk factors, and outcomes of immune effector cell-associated neurotoxicity syndrome following chimeric antigen receptor T cell therapy: a systematic review SJ Grant, AA Grimshaw, J Silberstein, D Murdaugh, TM Wildes, AE Rosko, ... Transplantation and cellular therapy 28 (6), 294-302, 2022 | 33 | 2022 |
| Myeloma in elderly patients: when less is more and more is more A Rosko, S Giralt, MV Mateos, A Dispenzieri American Society of Clinical Oncology Educational Book 37, 575-585, 2017 | 33 | 2017 |
